NECLIFE
Start SIP
Invest Now
Start SIP in NECLIFE
Performance
- Low
- ₹12
- High
- ₹13
- 52 Week Low
- ₹12
- 52 Week High
- ₹31
- Open Price₹13
- Previous Close₹13
- Volume401,545
- 50 DMA₹15.21
- 100 DMA₹16.17
- 200 DMA₹18.52
Investment Returns
- Over 1 Month -12.3%
- Over 3 Month -9.73%
- Over 6 Month -16.09%
- Over 1 Year -56.96%
Smart Investing Starts Here Start SIP with Nectar Lifesciences for Steady Growth!
Nectar Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -0.8
- PEG Ratio
- 0
- Market Cap Cr
- 283
- P/B Ratio
- 0.4
- Average True Range
- 0.54
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -0.94
- RSI
- 26.32
- MFI
- 30.26
Nectar Lifesciences Financials
Nectar Lifesciences Technicals
EMA & SMA
Current Price
₹12.62
-0.52
(-3.96%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹13.81
- 50 Day
- ₹15.21
- 100 Day
- ₹16.17
- 200 Day
- ₹18.52
Resistance and Support
12.79
- R3 13.86
- R2 13.56
- R1 13.09
- S1 12.32
- S2 12.02
- S3 11.55
Nectar Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & Others | To consider other business matters. |
| 2025-07-23 | Others | Inter alia amongst other items, the mode of rewarding of shareholders as contemplated in the explanatory statement to item no. 3 of Notice of 2025-26/01st EGM or matters related thereto. |
| 2025-07-07 | Audited Results |
Nectar Lifesciences F&O
About Nectar Lifesciences
- NSE Symbol
- NECLIFE
- BSE Symbol
- 532649
- Chairman & Managing Director
- Mr. Sanjiv Goyal
- ISIN
- INE023H01027
Similar Stocks to Nectar Lifesciences
Nectar Lifesciences FAQs
Nectar Lifesciences share price is ₹12 As on 21 February, 2026 | 06:04
The Market Cap of Nectar Lifesciences is ₹283 Cr As on 21 February, 2026 | 06:04
The P/E ratio of Nectar Lifesciences is -0.8 As on 21 February, 2026 | 06:04
The PB ratio of Nectar Lifesciences is 0.4 As on 21 February, 2026 | 06:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.